Wainer Andrea F 4
4 · ABBOTT LABORATORIES · Filed Feb 27, 2025
Insider Transaction Report
Form 4
Wainer Andrea F
EXECUTIVE VICE PRESIDENT
Transactions
- Award
Common shares without par value
2025-02-25+12,278→ 82,643 total - Award
Option (right to buy)
2025-02-25+45,730→ 45,730 totalExercise: $135.42From: 2026-02-25Exp: 2035-02-24→ Common Shares (45,730 underlying)
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,243 on February 25, 2026, 15,243 on February 25, 2027, and 15,244 on February 25, 2028.